Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.
about
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and ProgressionIdentification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapyCisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features.Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies.BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis.Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.
P2860
Q26744754-06780B26-17A9-4050-A44F-5249BB1257D2Q33572016-C9491B3D-02C1-4007-83B7-E33A0B23BDBEQ33827212-FC87F189-F874-4A5B-A28F-2FE06FDE14E7Q35106686-7989679D-5831-4C09-830F-3B3F8E983AD8Q35138841-1230A7C5-070F-44C6-8B3C-D4211CB9DD46Q36773974-B021603C-410A-4EEE-AEE7-3378D2775B4FQ36865011-8396919B-4646-4D3A-9AA8-2F3B3841CE88Q38222834-53C65DD5-9AD3-4CBB-AAD5-6659B0AEC16AQ38861044-BB1DFA2E-1C80-4B80-A4B6-83C6E59011CCQ39499034-29E6D043-F5BB-4D3A-9E56-B7EB721913C9Q42366566-C4B6BFC2-ED2A-4C1A-8913-F9C1B0C6DB06Q48119603-BD0B6E1F-DAA9-4016-8D95-8C99F1CCF996Q49874623-96BA29C5-8E69-4BB7-A8F6-B553D6687C6BQ52584371-AD0C544B-FA68-42CA-8EC4-F34B589794EEQ53075798-F83EFDDE-A9A8-4BCC-B40B-23D733308C45
P2860
Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@ast
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@en
type
label
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@ast
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@en
prefLabel
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@ast
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@en
P2093
P2860
P1433
P1476
Raloxifene inhibits growth of ...... d inhibition of proliferation.
@en
P2093
Carolyn L Smith
Kristi L Hoffman
Seth P Lerner
P2860
P2888
P356
10.1007/S12672-012-0123-9
P577
2012-09-11T00:00:00Z